Poseida Therapeutics Inc. buy BiotechBee
Start price
10.12.23
/
50%
€2.98
Target price
31.05.25
€4.00
Performance (%)
195.30%
End price
14.12.24
€8.80
Summary
This prediction ended on 14.12.24 with a price of €8.80. With a performance of 195.30% the BUY prediction by BiotechBee was a big success. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Poseida Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 1.432% | 1.580% | 13.249% |
| iShares Nasdaq 100 | 1.892% | -2.280% | 2.995% |
| iShares Nikkei 225® | -1.619% | 7.954% | 27.694% |
| iShares S&P 500 | 1.921% | -0.277% | 2.994% |
According to BiotechBee what are the pros and cons of Poseida Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Poseida Therapeutics Inc. diskutieren
Buy mit Kursziel 4,0
In the thread Trading Poseida Therapeutics Inc.
Buy beendet

